Results 151 to 160 of about 123,701 (265)
This study elucidates that β‐elemene promotes cellular uptake of L. gasseri‐derived lactate by enhancing the membrane translocation of MCT1 in a CD147‐dependent manner. Intracellular lactate, through the lactylation of RBBP4 at the K26 site, recruits EP300 to the promoter regions of downstream genes (POLD1/POLD3), catalyzing H3K27ac modification.
Jiancheng He +10 more
wiley +1 more source
This study identifies ARID3A as a key immunosuppressive transcription factor in TNBC. Its inhibition activates the type I IFN pathway, boosting CD8+ T cell infiltration and sensitizing tumors to anti‐PD‐1. The FDA‐approved migraine drug Rimegepant targets ARID3A, enhances immunotherapy efficacy in preclinical models, and establishes a druggable axis to
Teng Zhou +12 more
wiley +1 more source
NHE1-Mediated Metabolic Reprogramming in Cancer. [PDF]
Al-Hamaly MA, Forester BR, Blackburn JS.
europepmc +1 more source
Advanced Metabolic Reprogramming
This white paper presents the most advanced cancer termination matrix ever developed — a clinically deployable, AI-adaptable, and biotech-compatible kill-switch architecture. At its core lies a 71×45 high-dimensional therapeutic matrix, comprising over 3,000 mechanistic nodes and more than 5,000 total data entries.
openaire +2 more sources
This study demonstrates that iron overload triggers widespread chromatin compaction and transcriptional repression in human granulosa cells, recapitulating features of endometriosis. The epigenetic reprogramming is orchestrated by a TFEB‐SOX4‐SWI/SNF axis, with SOX4 acting as a central, dosage‐sensitive regulator.
Feifei Li +15 more
wiley +1 more source
Metabolism and Metabolic Reprogramming in Laryngeal Squamous Cell Carcinoma. [PDF]
Verro B +7 more
europepmc +1 more source
ABSTRACT Advancements in tissue engineering have revolutionized therapeutic paradigms for diabetic tissue defects; however, the lack of applicable scaffold containing various bioactive substance aggregates remained a critical bottleneck hindering satisfactory repair effect.
Tao Wang +8 more
wiley +1 more source
The metabolic escape: how tumor metabolic reprogramming drives drug resistance. [PDF]
Chen Y, Wu Z, Si W, Liu X.
europepmc +1 more source
RBM10 deficiency promotes anti‐PD‐1 resistance in lung adenocarcinoma by altering STING alternative splicing, which enhances CCL7 secretion and CCR2‐dependent M2 macrophage polarization. A positive feedback loop via mitochondrial transfer sustains this immunosuppression.
Weitong Gao +14 more
wiley +1 more source
Hypoxic microenvironment in cancer: role in metabolic reprogramming. [PDF]
Sureka N +8 more
europepmc +1 more source

